Perfusion Imaging and Clinical Outcome in Acute Minor Stroke With Large Vessel Occlusion.

  • Pierre Seners
  • Caroline Arquizan
  • Louis Fontaine
  • Wagih Ben Hassen
  • Mirjam R Heldner
  • Davide Strambo
  • Simon Nagel
  • Emmanuel Carrera
  • Laura Mechtouff
  • Margy McCullough-Hicks
  • Mahmoud H Mohammaden
  • Jean-Philippe Cottier
  • Hilde Henon
  • Andreea Aignatoaie
  • Nadia Laksiri
  • Jérémie Papassin
  • Ludovic Lucas
  • Pierre Garnier
  • Aude Triquenot
  • Gioia Mione
  • Steven Hajdu
  • Vincent Costalat
  • Arne Potreck
  • Olivier Detante
  • Fabrice Bonneville
  • Yves Berthezene
  • Serge Bracard
  • Igor Sibon
  • Nicolas Bricout
  • Claire Boutet
  • Pasquale Mordasini
  • Patrik Michel
  • Catherine Oppenheim
  • Jean-Marc Olivot
  • Raul G Nogueira
  • Gregory W Albers
  • Jean-Claude Baron
  • Guillaume Turc
  • Christophe Cognard
  • Gaultier Marnat
  • Patrice Menegon
  • Sylvain Ledure
  • Cyril Dargazanli
  • Tae-Hee Cho
  • Norbert Nighoghossian
  • Omer Eker
  • Sylvain Gouttard
  • Diogo Haussen
  • Séverine Debiais
  • Vladimir Charron
  • Nicolas Charron
  • Didier Leys
  • Canan Ozsancak
  • Mathilde Delpech
  • Hervé Brunel
  • Chrysanti Papagiannaki
  • Emmanuel Girardin
  • Sébastien Richard
  • Benjamin Gory
  • Martin Zbinden
  • Tomas Dobrocky
  • Peter Ringelb
  • Markus Möhlenbruch

Source: Stroke

Publié le

Résumé

BACKGROUND: Whether bridging therapy (intravenous thrombolysis [IVT] followed by mechanical thrombectomy) is superior to IVT alone in minor stroke with large vessel occlusion is unknown. Perfusion imaging may identify subsets of large vessel occlusion-related minor stroke patients with distinct response to bridging therapy.

METHODS: We conducted a multicenter international observational study of consecutive IVT-treated patients with minor stroke (National Institutes of Health Stroke Scale score ≤5) who had an anterior circulation large vessel occlusion and perfusion imaging performed before IVT, with a subset undergoing immediate thrombectomy. Propensity score with inverse probability of treatment weighting was used to account for baseline between-groups differences. The primary outcome was 3-month modified Rankin Scale score 0 to 1. We searched for an interaction between treatment group and mismatch volume (critical hypoperfusion-core volume).

RESULTS: Overall, 569 patients were included (172 and 397 in the bridging therapy and IVT groups, respectively). After propensity-score weighting, the distribution of baseline variables was similar across the 2 groups. In the entire population, bridging was associated with lower odds of achieving modified Rankin Scale score 0 to 1: odds ratio, 0.73 [95% CI, 0.55-0.96]; P=0.03. However, mismatch volume modified the effect of bridging on clinical outcome (Pinteraction=0.04 for continuous mismatch volume); bridging was associated with worse outcome in patients with, but not in those without, mismatch volume <40 mL (odds ratio, [95% CI] for modified Rankin Scale score 0-1: 0.48 [0.33-0.71] versus 1.14 [0.76-1.71], respectively). Bridging was associated with higher incidence of symptomatic intracranial hemorrhage in the entire population, but this effect was present in the small mismatch subset only (Pinteraction=0.002).

CONCLUSIONS: In our population of large vessel occlusion-related minor stroke patients, bridging therapy was associated with lower rates of good outcome as compared with IVT alone. However, mismatch volume was a strong modifier of the effect of bridging therapy over IVT alone, notably with worse outcome with bridging therapy in patients with mismatch volume ≤40 mL. Randomized trials should consider adding perfusion imaging for patient selection.